In this engaging conversation, we delve into the world of pharmaceutical innovation and collaboration. Our guest, Dr. Nedim Pipic, a pharmaceutical expert specializing in mental and retinal health, shares his journey and passion for making a difference.

Quitting is a valuable skill. It’s important for dealing with uncertainty, yet we are quite bad at exercising it. It should not be just about sticking to things. Quitting is also good, particularly when we have to start most things. Persisting at something when it’s worthwhile is definitely a good character trait but persisting at something when it’s no longer worthwhile is not a good character trait. Calibrate around the notion, “is it worthwhile to stick? "

The speed of Recursion is remarkable in delivering a value proposition. Michael Secora, Chief Financial Officer at Recursion, expounds on data relatability, building various data sets, and leveraging data sets to build a next-generation biopharmaceutical company! Moreover, he shares tips on standing out amongst competitors and what differentiates Recursion from other AI discovery companies.

An interview with Kabir Nath, President & CEO, Otsuka North America Pharmaceutical Business, covering innovation, Kabir's personal journey, culture, technology, books and more...

An interview with Dr Kat Arney, author of Rebel Cell (Note: some sensitive language content) Many of us think of cancer as a contemporary killer, a disease of our own making caused by our modern lifestyles. But, as Kat Arney explains in her new book REBEL CELL: Cancer Evolution and the Science of Life, that perception just isn’t true.

An interview with Susanne Schaffert, President of Novartis Oncology, touching on innovation, cultures of innovation and the leadership approach she brings, as well as great insight into her early years.

In this interview, we discuss Lilly's remarkable performance as the most innovative pharma company on the 2021 Pharmaceutical Innovation and Invention Index, about cultures of innovation, Lilly's approach to delegated decision making and biotech-like process, among other things.

A conversation about The Alignment Problem with author Brian Christian. On what we want and what we expect from our machine learning systems...

Interview with Nick Wood and Benji Compston of Syn.

Riccardo Zacconi is an Italian businessman, best known as CEO of King, a company he founded in 2003. King is the developer of the popular mobile games app Candy Crush Saga, that was sold for $5.9 billion in 2016. In this interview, we discuss innovation in a world adjacent to pharma, and look for similarities and differences.